Literature DB >> 26488629

Incidence of Stevens-Johnson Syndrome and Chemical Burns to the Eye.

Michelle L White1, James Chodosh, Jisun Jang, Claes Dohlman.   

Abstract

PURPOSE: This population-based observational study was designed to estimate the incidence and distribution of SJS-spectrum (Stevens-Johnson syndrome, toxic epidermal necrolysis, and toxic epidermal Necrolysis/Stevens-Johnson syndrome overlap) and chemical burns (alkali or acid burn of the cornea/conjunctiva) in the United States and extrapolate these numbers to the world.
METHODS: All patients evaluated in 961 hospital-based US emergency departments between July 1, 2010, and June 30, 2012 were identified retrospectively using the Nationwide Emergency Department Sample (NEDS) from the Agency for Healthcare Research and Quality. SJS-spectrum and chemical burn cases were identified using the International Classification of Diseases, Ninth Revision, Clinical Modification diagnostic codes.
RESULTS: A mean of 3834 new SJS-spectrum cases per year were identified in the United States, resulting in an incidence rate of 12.35 new cases per million per year. Similarly, a mean of 15,865 new chemical burn cases per year were identified, resulting in an incidence rate of 51.10 new cases per million per year.
CONCLUSIONS: If the incidence of SJS-spectrum is approximately uniform the world-over, extrapolation from the US figure would amount to approximately 86,500 new cases per year in the world. Extrapolation of ocular chemical burns to the world is difficult because the incidence and severity are anticipated to be higher in the developing world than in the United States. Still, using a US incidence rate, a minimum of 357,710 burn accidents would be expected to occur worldwide every year; there are presently too few data available to calculate the degree of severity and bilaterality.

Entities:  

Mesh:

Year:  2015        PMID: 26488629     DOI: 10.1097/ICO.0000000000000646

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  12 in total

1.  [Ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis].

Authors:  Argyrios Chronopoulos; Maja Mockenhaupt; Uwe Pleyer
Journal:  Ophthalmologe       Date:  2021-03-16       Impact factor: 1.059

2.  A Retrospective Cohort Study of the Management and Outcomes of Children Hospitalized with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis.

Authors:  James W Antoon; Jennifer L Goldman; Samir S Shah; Brian Lee
Journal:  J Allergy Clin Immunol Pract       Date:  2018-05-30

Review 3.  An update on chemical eye burns.

Authors:  Mukhtar Bizrah; Ammar Yusuf; Sajjad Ahmad
Journal:  Eye (Lond)       Date:  2019-05-13       Impact factor: 3.775

4.  Toxic epidermal necrolysis: the red eye and red herrings in casualty.

Authors:  Robert J Barry; Ulises Zanetto; Sai Kolli; Rupal Morjaria
Journal:  BMJ Case Rep       Date:  2018-10-12

5.  Clinical Characteristics of Patients With Chronic Stevens-Johnson Syndrome Treated at a Major Tertiary Eye Hospital Within the United Kingdom.

Authors:  Samir Jabbour; Nizar Din; Abison Logeswaran; Sara Taberno Sanchez; Sajjad Ahmad
Journal:  Front Med (Lausanne)       Date:  2021-05-24

6.  Propranolol eye drops in patients with corneal neovascularization.

Authors:  Luca Filippi; Cinzia de Libero; Barbara Zamma Gallarati; Pina Fortunato; Elena Piozzi
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

Review 7.  Genetic Markers for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in the Asian Indian Population: Implications on Prevention.

Authors:  Swapna S Shanbhag; Madhuri A Koduri; Chitra Kannabiran; Pragnya R Donthineni; Vivek Singh; Sayan Basu
Journal:  Front Genet       Date:  2021-01-12       Impact factor: 4.599

8.  USA: Ophthalmologic Evaluation and Management of Acute Stevens-Johnson Syndrome.

Authors:  Darren G Gregory
Journal:  Front Med (Lausanne)       Date:  2021-07-07

9.  Chemical Burns of the Eye: The Role of Retinal Injury and New Therapeutic Possibilities.

Authors:  Claes H Dohlman; Fabiano Cade; Caio V Regatieri; Chengxin Zhou; Fengyang Lei; Alja Crnej; Mona Harissi-Dagher; Marie-Claude Robert; George N Papaliodis; Dongfeng Chen; James V Aquavella; Esen K Akpek; Anthony J Aldave; Kimberly C Sippel; Donald J DʼAmico; Jan G Dohlman; Per Fagerholm; Liqiang Wang; Lucy Q Shen; Miguel González-Andrades; James Chodosh; Kenneth R Kenyon; C Stephen Foster; Roberto Pineda; Samir Melki; Kathryn A Colby; Joseph B Ciolino; Demetrios G Vavvas; Shigeru Kinoshita; Reza Dana; Eleftherios I Paschalis
Journal:  Cornea       Date:  2018-02       Impact factor: 3.152

Review 10.  Recent Advances in Stem Cell Therapy for Limbal Stem Cell Deficiency: A Narrative Review.

Authors:  Ali E Ghareeb; Majlinda Lako; Francisco C Figueiredo
Journal:  Ophthalmol Ther       Date:  2020-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.